2 research outputs found
Synthesis and in-vitro evaluation of s-allyl cysteine ester-caffeic acid amide hybrids as potential anticancer agents
We have synthesized a series of S-allyl cysteine ester-caffeic acid amide hybrids and evaluated them in order to determine their possible anticancer activity and selectivity in colorectal cancer, which is still one of the leading causes of morbidity and mortality worldwide. All compounds were tested against SW480 human colon adenocarcinoma cells and the non-malignant CHO-K1 cell line. Among the tested compounds, hybrids 6e, 9a, 9b, 9c and 9e exhibited the highest effect on viability (IC50 SW480-48h= 0.18, 0.12, 0.12, 0.11 and 0.12 mM, respectively) and selectivity (SI= 10.3, 1.5, >83.33, >90.91 and >83.33, respectively) in a time- and concentration-dependent manner. Besides, our results were even better as regards lead compounds (S-allyl cysteine and caffeic acid) and the standard drug (5-FU). Additionally, these five compounds induced mitochondrial depolarization that could be related with an apoptotic process. Moreover, hybrids 6e, 9a and 9e induced cell cycle arrest in G2/M phase, and compound 9c in S- phase, which suggests that these hybrid compounds could have also a cytostatic effect in SW480 cell line. The SAR analysis showed that hydroxyl groups increased the activity, besides, there was not a clear relationship between the antitumor properties and the length of the alkyl chain. Since hybrid compounds were much more selective than the conventional drug (5-FU), this make them promising candidates for further studies against colorectal cancer
Synthesis and Antiproliferative Activity of 3 and 7-Styrylcoumarins
A series of styrylcoumarins were obtained via Mizoroki-Heck reactions between 3-bromo-4-methyl7-(octyloxy)-2H-chromen-2-one
or 2-oxo-2H-chromen-7-yl trifluoromethanesulfonate and
functionalized styrenes. The structures of the products were elucidated by spectroscopic analysis.
All compounds were evaluated against SW480 and CHO-K1 cell lines. A number of hybrids
showed good antiproliferative activity. Among the tested compounds, hybrids 6e, 10c and 10d,
exhibited the highest activity (IC50- SW480/48h = 6,92; 1,01 and 5,33 µM, respectively) and selectivity
(IS48h = >400; 67,8 and 7,2, respectively). In addition, these compounds were able to preserve their
activities over time. The results achieved by these hybrids were even better than the lead
compounds (coumarin and resveratrol) and the standard drug (5-FU). As regards structure-activity
relationship it seems that the location of the styryl group on the coumarin structure and the presence
of the hydroxyl group on the phenyl ring were determinant for the activity